Selecting individualized treatment for patients with ductal carcinoma in situ of the breast: The search continues

Journal of Clinical Oncology

Volumn 30, Issue 6, 2012, Pages 577-579

  Solin, Lawrence J ^a  

^a ALBERT EINSTEIN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TAMOXIFEN;

AGE; BREAST BIOPSY; BREAST CALCIFICATION; CANCER CHEMOTHERAPY; CANCER HORMONE THERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RISK; CANCER SCREENING; CANCER SURVIVAL; CLINICAL DECISION MAKING; CLINICAL PRACTICE; EDITORIAL; FAMILY HISTORY; HEALTH CARE COST; HORMONAL THERAPY; HUMAN; INTRADUCTAL CARCINOMA; MAMMOGRAPHY; MEDICAL DECISION MAKING; NOMOGRAM; PARTIAL MASTECTOMY; PATIENT SAFETY; PREDICTION; PRIORITY JOURNAL; REOPERATION; TREATMENT RESPONSE; TUMOR VOLUME;

BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; FEMALE; HUMANS; MASTECTOMY, SEGMENTAL; NEOPLASM RECURRENCE, LOCAL; NOMOGRAMS;

EID: 84857517254     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2011.39.6929     Document Type: Editorial

References (32)

1. Allegra CJ, Aberle DR, Ganschow P, et al: National Institutes of Health state-of-the-science conference statement: Diagnosis and management of ductal carcinoma in situ September 22-24, 2009. J Natl Cancer Inst 102:161-169, 2010
2. Burstein HJ, Polyak K, Wong JS, et al: Ductal carcinoma in situ of the breast. N Engl J Med 350:1430-1441, 2004 (Pubitemid 38419997)
3. Schwartz GF, Solin LJ, Olivotto IA, et al: Consensus conference on the treatment of in situ ductal carcinoma of the breast, April 22-25, 1999. Cancer 88:946-954, 2000 (Pubitemid 30091115)
4. Kane RL, Virnig BA, Shamliyan T, et al: The impact of surgery, radiation, and systemic treatment on outcomes in patients with ductal carcinoma in situ. J Natl Cancer Inst Monogr 41:130-133, 2010
5. Solin LJ: The impact of adding radiation treatment after breast conservation surgery for ductal carcinoma in situ of the breast. J Natl Cancer Inst Monogr 41:187-192, 2010
6. Baxter NN, Virnig BA, Durham SB, et al: Trends in the treatment of ductal carcinoma in situ of the breast. J Natl Cancer Inst 96:443-448, 2004 (Pubitemid 38443647)
7. Smith GL, Smith BD, Haffty BG: Rationalization and regionalization of treatment for ductal carcinoma in situ of the breast. Int J Radiat Oncol Biol Phys 65:1397-1403, 2006 (Pubitemid 44425216)
8. Fisher B, Dignam J, Wolmark N, et al: Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: Findings from National Surgical Adjuvant Breast and Bowel Project B-17. J Clin Oncol 16:441-452, 1998 (Pubitemid 28135585)
9. Fisher B, Land S, Mamounas E, et al: Prevention of invasive breast cancer in women with ductal carcinoma in situ: An update of the National Surgical Adjuvant Breast and Bowel Project experience. Semin Oncol 28:400-418, 2001 (Pubitemid 32762083)
10. Wapnir IL, Dignam JJ, Fisher B, et al: Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS. J Natl Cancer Inst 103:478-488, 2011
11. Cuzick J, Sestak I, Pinder SE, et al: Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: Long-term results from the UK/ANZ DCIS trial. Lancet Oncol 12:21-29, 2011
12. Bijker N, Meijnen P, Peterse JL, et al: Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-situ: Ten-year results of European Organisation for Research and Treatment of Cancer randomized phase III trial 10853 - A study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group. J Clin Oncol 24:3381-3387, 2006 (Pubitemid 46638893)
13. Bijker N, Peterse JL, Duchateau L, et al: Risk factors for recurrence and metastasis after breast-conserving therapy for ductal carcinoma-in-situ: Analysis of European Organization for Research and Treatment of Cancer Trial 10853. J Clin Oncol 19:2263-2271, 2001 (Pubitemid 32366979)
14. Holmberg L, Garmo H, Granstrand B, et al: Absolute risk reductions for local recurrence after postoperative radiotherapy after sector resection for ductal carcinoma in situ of the breast. J Clin Oncol 26:1247-1252, 2008
15. Correa C, McGale P, Taylor C, et al: Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast. J Natl Cancer Inst Monogr 41:162-177, 2010
16. Fisher B, Dignam J, Wolmark N, et al: Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial. Lancet 353:1993-2000, 1999 (Pubitemid 29271743)
17. Rudloff U, Jacks LM, Goldberg JI, et al: Nomogram for predicting the risk of local recurrence after breast-conserving surgery for ductal carcinoma in situ. J Clin Oncol 28:3762-3769, 2010
18. Memorial Sloan-Kettering Cancer Center: Breast cancer nomogram: Ductal carcinoma in situ (DCIS) recurrence. http://nomograms.mskcc.org/Breast/ DuctalCarcinomaInSituRecurrencePage.aspx
19. Yi M, Meric-Bernstam F, Kuerer HM, et al: Evaluation of a breast cancer nomogram for predicting risk of ipsilateral breast tumor recurrences in patients with ductal carcinoma in situ after local excision. J Clin Oncol 30:600-607, 2012
20. Lagios MD, Westdahl PR, Margolin FR, et al: Duct carcinoma in situ: Relationship of extent of noninvasive disease to the frequency of occult invasion, multicentricity, lymph node metastases, and short-term treatment failures. Cancer 50:1309-1314, 1982 (Pubitemid 12031954)
21. Lagios MD, Richards VE, Rose MR, et al: Segmental mastectomy without radiotherapy: Short-term follow-up. Cancer 52:2173-2179, 1983 (Pubitemid 14232265)
22. Lagios MD, Margolin FR, Westdahl PR, et al: Mammographically detected duct carcinoma in situ: Frequency of local recurrence following tylectomy and prognostic effect of nuclear grade on local recurrence. Cancer 63:618-624, 1989 (Pubitemid 19050259)
23. Wong JS, Kaelin CM, Troyan SL, et al: Prospective study of wide excision alone for ductal carcinoma in situ of the breast. J Clin Oncol 24:1031-1036, 2006 (Pubitemid 46638798)
24. Hughes LL, Wang M, Page DL, et al: Local excision alone without irradiation for ductal carcinoma in situ of the breast: A trial of the Eastern Cooperative Oncology Group. J Clin Oncol 27:5319-5324, 2009
25. Silverstein MJ, Lagios MD: Choosing treatment for patients with ductal carcinoma in situ: Fine tuning the University of Southern California/Van Nuys Prognostic Index. J Natl Cancer Inst Monogr 41:193-196, 2010
26. Silverstein MJ, Lagios MD, Groshen S, et al: The influence of margin width on local control of ductal carcinoma in situ of the breast. N Engl J Med 340:1455-1461, 1999 (Pubitemid 29220544)
27. Solin LJ, Gray R, Baehner FL, et al: A quantitative multigene RT-PCR assay for predicting recurrence risk after surgical excision alone without irradiation for ductal carcinoma in situ (DCIS): A prospective validation study of the DCIS score from ECOG E5194. Presented at the San Antonio Breast Cancer Symposium, San Antonio, TX, December 6-10, 2011 (abstr S4-6)
28. Polyak K: Molecular markers for the diagnosis and management of ductal carcinoma in situ. J Natl Cancer Inst Monogr 41:210-213, 2010
29. Freedman MT: Imaging: New techniques, in Harris JR, Lippman ME, Morrow M, et al (eds): Diseases of the Breast (ed 4). Philadelphia, PA, Lippincott Williams & Wilkins, 2010, pp 171-192
30. Roth SO: Imaging analysis: Magnetic resonance imaging, in Harris JR, Lippman ME, Morrow M, et al (eds): Diseases of the Breast (ed 4). Philadelphia, PA, Lippincott Williams & Wilkins, 2010, pp 152-170
31. Pisano ED: Mode of detection and secular time for ductal carcinoma in situ. J Natl Cancer Inst Monogr 41:142-144, 2010
32. Lehman CD: Magnetic resonance imaging in the evaluation of ductal carcinoma in situ. J Natl Cancer Inst Monogr 41:150-151, 2010